BioCentury | Feb 24, 2021
Deals

Feb. 23 Quick Takes: BGI raises $300M, plus a $230M C round for Clover, Day One, Waksal’s Graviton, Asalyxa

...investors also participated in the round including Northern Light Venture Capital, Kaitai Capital and Oriental Fortune Capital...
BioCentury | Apr 30, 2020
Finance

Shiyu backs Mabwell’s massive series A following close of second fund

...of megarounds, leading Mabwell’s RMB2 billion ($279.1 million) series A financing. Also participating were Oriental Fortune Capital...
BioCentury | Jan 9, 2020
Financial News

Jan. 8 Financial Quick Takes: Intra-Cellular raises $295M; plus venture rounds for nference, Eyevensys, Transcenta, Airway, Progentec

...the total amount raised in the round to $100 million. CR-CP Life Science Fund and Fortune Capital...
BioCentury | Feb 15, 2019
Financial News

TCR2 raises $75M in IPO

...early 2020. Shareholders in TCR2 include MPM Capital, F2 Capital, UBS Oncology Impact Fund, Cathay Fortune Capital...
BioCentury | Feb 14, 2019
Financial News

TCR2 prices $75M IPO at midpoint

...early 2020. Shareholders in TCR2 include MPM Capital, F2 Capital, UBS Oncology Impact Fund, Cathay Fortune Capital...
BioCentury | Jan 4, 2019
Financial News

TCR2 seeks IPO as first program slated to enter clinic

...institutional investors holding more than a 5% stake include UBS Oncology Impact Fund (14.9%), Cathay Fortune Capital...
BioCentury | Dec 28, 2018
Financial News

TCR2 seeks IPO as first program slated to enter clinic

...institutional investors holding more than a 5% stake include UBS Oncology Impact Fund (14.9%), Cathay Fortune Capital...
BioCentury | Jul 20, 2018
Financial News

CanSino latest to file for HKEX IPO

...The company’s investor base also includes Lilly Asia Ventures, Qiming Venture Partners, SDIC, CITIC Investment, Fortune Capital...
BioCentury | Jul 17, 2018
Financial News

CanSino latest to file for HKEX IPO

...The company’s investor base also includes Lilly Asia Ventures, Qiming Venture Partners, SDIC, CITIC Investment, Fortune Capital...
BioCentury | Jul 17, 2018
Financial News

CanSino latest to file for HKEX IPO

...The company’s investor base also includes Lilly Asia Ventures, Qiming Venture Partners, SDIC, CITIC Investment, Fortune Capital...
Items per page:
1 - 10 of 16
BioCentury | Feb 24, 2021
Deals

Feb. 23 Quick Takes: BGI raises $300M, plus a $230M C round for Clover, Day One, Waksal’s Graviton, Asalyxa

...investors also participated in the round including Northern Light Venture Capital, Kaitai Capital and Oriental Fortune Capital...
BioCentury | Apr 30, 2020
Finance

Shiyu backs Mabwell’s massive series A following close of second fund

...of megarounds, leading Mabwell’s RMB2 billion ($279.1 million) series A financing. Also participating were Oriental Fortune Capital...
BioCentury | Jan 9, 2020
Financial News

Jan. 8 Financial Quick Takes: Intra-Cellular raises $295M; plus venture rounds for nference, Eyevensys, Transcenta, Airway, Progentec

...the total amount raised in the round to $100 million. CR-CP Life Science Fund and Fortune Capital...
BioCentury | Feb 15, 2019
Financial News

TCR2 raises $75M in IPO

...early 2020. Shareholders in TCR2 include MPM Capital, F2 Capital, UBS Oncology Impact Fund, Cathay Fortune Capital...
BioCentury | Feb 14, 2019
Financial News

TCR2 prices $75M IPO at midpoint

...early 2020. Shareholders in TCR2 include MPM Capital, F2 Capital, UBS Oncology Impact Fund, Cathay Fortune Capital...
BioCentury | Jan 4, 2019
Financial News

TCR2 seeks IPO as first program slated to enter clinic

...institutional investors holding more than a 5% stake include UBS Oncology Impact Fund (14.9%), Cathay Fortune Capital...
BioCentury | Dec 28, 2018
Financial News

TCR2 seeks IPO as first program slated to enter clinic

...institutional investors holding more than a 5% stake include UBS Oncology Impact Fund (14.9%), Cathay Fortune Capital...
BioCentury | Jul 20, 2018
Financial News

CanSino latest to file for HKEX IPO

...The company’s investor base also includes Lilly Asia Ventures, Qiming Venture Partners, SDIC, CITIC Investment, Fortune Capital...
BioCentury | Jul 17, 2018
Financial News

CanSino latest to file for HKEX IPO

...The company’s investor base also includes Lilly Asia Ventures, Qiming Venture Partners, SDIC, CITIC Investment, Fortune Capital...
BioCentury | Jul 17, 2018
Financial News

CanSino latest to file for HKEX IPO

...The company’s investor base also includes Lilly Asia Ventures, Qiming Venture Partners, SDIC, CITIC Investment, Fortune Capital...
Items per page:
1 - 10 of 16